Harvard Bioscience reports Q4 revenue of $23.7M, outlines growth strategy
Go back to Harvard Bioscience reports Q4 revenue of $23.7M, outlines growth strategy| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 8.04 -0.07 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.11 | 52 Week High | $3.90 | |||
| Open | $8.13 | 52 Week Low | $2.25 | |||
| Day High | $8.26 | P/E | N/A | |||
| Day Low | $8.00 | EPS | $-0.03 | |||
| Volume | 20,899 | |||||

